Cardiovascular Disease Prevention Continuing Medical Education, CME, Medical Conference - Baptist Health
Skip Ribbon Commands Skip to main content
Cardiovascular Disease Prevention
14th Annual International Symposium
Thursday-Friday, February 18-20, 2016
Trump National Doral, Miami, Florida

2016 Faculty________________________

Faculty Disclosures coming soon.


Michael Ozner, M.D., FACC, FAHA
Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Miami, Florida
Biography   Dr. Ozner is one of America’s leading advocates for heart disease prevention. He is a well-known regional and national speaker in the field of preventive cardiology. Dr. Ozner has frequently appeared in the print, radio and television media including The New York Times, NPR radio and CBS News. He was the recipient of the 2008 American Heart Association Humanitarian Award and has been elected to Top Cardiologists in America by the Consumer Council of America. Dr. Ozner is also the author of The Great American Heart Hoax and Heart Attack Proof. His most recent book, The Complete Mediterranean Diet, was released worldwide April 2014.

Theodore Feldman, M.D., FACC, FACP

Medical Director, Center for Prevention and Wellness, Baptist Health
Medical Director, Prevention and Community Health, Miami Cardiac and Vascular Institute
Clinical Associate Professor of Medicine, FIU Wertheim College of Medicine

Miami, Florida

Biography   Dr. Ted Feldman is extensively involved in clinical research and education in cardiovascular disease prevention. He serves as a Symposium Director for the International Symposium on Cardiovascular Disease Prevention, one of the largest and most prestigious such meetings in the US. He also is Symposium Director of the Miami Cardiac & Vascular Institute Comprehensive Cardiovascular Symposium. Board-certified in internal medicine with a subspecialty in cardiovascular medicine, Dr. Feldman currently serves as Medical Director of Miami Cardiac & Vascular Institute at South Miami Hospital and is a Medical Director for the Center for Prevention and Wellness at Baptist Health South Florida. Dr. Feldman is a Clinical Associate Professor of Medicine at the FIU Herbert Wertheim College of Medicine as well as the Cardiology Clerkship director at FIU and an interviewer for the FIU HWCOM Admissions committee. Dr. Feldman is in private practice in South Miami and is a member of the Executive Committee and Board of Directors of Heartwell LLP, a large single specialty cardiovascular practice closely affiliated with Miami Cardiac & Vascular Institute.  

Arthur S. Agatston, M.D., FACC
Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Cardiologist, Baptist Hospital of Miami
Professor, Florida International University Herbert Wertheim College of Medicine
Associate Professor of Medicine, University of Miami Miller School of Medicine
Miami, Florida
Biography   Dr. Agatston’s work with Dr. Warren Janowitz resulted in the Agatston Score, a method of screening for coronary calcium as an indicator of atherosclerosis that is used at medical centers throughout the world and considered by most experts to be the best single predictor of a future heart attack. Known as the author of the internationally best-selling book, The South Beach Diet, his first nonacademic work, Dr. Agatston created his balanced approach to healthy eating to help his patients improve their blood chemistries and lose weight. Today, the South Beach Diet is the trusted choice of millions and there are more than 23 million copies of     Dr. Agatston has published more than 100 scientific articles and abstracts in medical journals and is a frequent lecturer across the U.S. and around the world on diet, cardiac imaging, and the prevention of heart disease. In recognition of his contributions to cardiac prevention, the Society of Cardiovascular Computed Tomography (SCCT) created the prestigious Arthur S. Agatston Cardiovascular Disease Prevention Award in 2011, which is given annually to pioneers in cardiac prevention.

Khurram Nasir, M.D., MPH
Research Director, Center for Prevention and Wellness
Director, High-risk Cardiovascular Disease Clinic
Baptist Health South Florida, Miami, Florida
Assistant Professor, Johns Hopkins Ciccarone Center for Preventive Cardiology
Baltimore, Maryland
Biography   Dr. Nasir’s area of expertise lies in population health management, role of cardiovascular imaging for identification of high-risk individuals with a particular emphasis on innovative health care delivery based paradigms to improve patient outcomes and appropriate resource allocation. Dr. Nasir is a recipient of the NIH training award for cardiac imaging training program at the Massachusetts General Hospital, Boston, USA. Dr. Nasir has published more than 290 publications in his area of interest. He is an Associate Editor for the journal, “Atherosclerosis”, “Circulation: Cardiovascular Quality and Outcomes” and “Journal of American Cardiology: Cardiac Imaging” as well serves on the editorial board for the Journal of Cardiac CT. He is currently the chair of prevention council for the Society of Atherosclerosis Imaging and Prevention as well member of board of directors for Society for Cardiac CT (SCCT). He was awarded in 2013 for his contributions the “Johns Hopkins Distinguished Alumni Award”, which honors alumni who have typified the Johns Hopkins tradition of excellence and brought credit to the University by their personal accomplishment, professional achievement, or humanitarian service.


Harry Aldrich M.D.

Baptist, Doctors, South Miami Hospitals
Miami Cardiac & Vascular Institute
Biography   Dr. Harry Aldrich specializes in diagnostic and preventive cardiology and is a graduate of Princeton University and Duke University School of Medicine. He completed his residency in internal medicine at Duke University Medical Center and his fellowship in cardiology at the New York Presbyterian Hospital Cornell Medical Center. Dr. Aldrich is currently chairman of the Echocardiography Committee and has served as Chief of Cardiology, Vice Chairman of the Cardiovascular Service Line, and as a member of the Medical Executive Committee at South Miami Hospital. He serves on many other hospital committees and is board certified in cardiology.


James Benenati, M.D., FSCIR, FAHA

Medical Director, Peripheral Vascular Laboratory
Clinical Associate Professor of Radiology
University of South Florida College of Medicine
Program Director, ACGME- Accredited Fellowship Program in Interventional Radiology
Miami Cardiac & Vascular Institute
Diagnostic Radiologist Vascular & Interventional Radiologist
Baptist, Doctors, Homestead, South Miami and West Kendall Baptist Hospitals
Miami, Florida
Biography   Dr. Benenati joined Miami Cardiac & Vascular Institute in 1990. He received his bachelor's degree from the University of Notre Dame and his medical degree from the University of South Florida College of Medicine. He completed a residency in diagnostic radiology at Indiana University Medical Center and a fellowship in cardiovascular and interventional radiology at Johns Hopkins Medical School. Dr. Benenati is Past President of the Society of Interventional Radiology and served on the Executive Council of the Society of Interventional Radiology in a variety of positions including Annual Meeting Chairman. He is a past president of the Intersociety Commission for the Accreditation of Vascular Laboratories (ICAVL). Dr. Benenati has participated in clinical research projects for abdominal aortic aneurysm repair with endografts; stents in peripheral vascular disease; prevention of restenosis in the femoral and popliteal arteries and in carotid stenting trials. He has participated in national trials evaluating uterine embolization for the treatment of symptomatic fibroids and has organized national educational symposia regarding fibroid embolization. In addition to lecturing internationally, Dr. Benenati has authored and co-authored over 100 scientific article and abstracts that have been published in medical journals including the Journal of the American Medical Association, Radiology, Journal of Vascular & Interventional Radiology and Journal of Vascular Surgery. He has also edited medical textbooks dealing with different aspects of interventional radiology, and is active in educational activities for the SIR.


Ian del Conde Pozzi, M.D.

Cardiovascular Disease, Vascular Medicine
Baptist, Doctors, Homestead and West Kendall Baptist Hospitals
Miami, Florida
Biography   Dr. del Conde Pozzi’s clinical expertise involves the study and treatment of diseases that affect the arterial, venous, and lymphatic systems, including peripheral artery disease, carotid and renal artery disease, resistant hypertension, venous thromboembolic disease, venous insufficiency and less common vascular diseases, such as fibromuscular dysplasia, and vasculitis. Dr. del Conde Pozzi has focused his career on the study of thrombosis and vascular diseases. He has published widely in the field of cardiovascular diseases and is the author of several scientific articles and book chapters and has been an invited speaker at several international medical meetings.


Lisardo Garcia-Covarrubias, M.D., FACS

Clinical Associate Professor of Surgery
Florida International University Herbert Wertheim College of Medicine
Chief, Cardiothoracic Surgery
Baptist and South Miami Hospitals
Miami, Florida
Biography   Dr. Garcia-Covarrubias completed a cardiothoracic transplant fellowship at University of Pittsburgh Medical Center following a thoracic surgery residency and transplant fellowship at the University of Miami-Jackson Memorial Hospital, where he was also chief administrative cardiothoracic resident. He came to Miami when a trauma and surgical critical care fellowship at Tulane University School of Medicine was interrupted by Hurricane Katrina. Previous to the fellowship, he had completed a residency in general surgery at Tulane University School of Medicine. He also completed research and clinical fellowships in hyperbaric medicine. He is Board-certified by the American Board of Surgery and the American Board of Thoracic Surgery. He has lectured and published more than 15 articles in peer-reviewed journals. His special interests include treating patients with end stage heart disease and mechanical circulatory support.


Marcus E. St. John M.D.

Cardiologist, Baptist, South Miami and West Kendall Baptist Hospitals
Miami, Florida
Biography   Dr. St. John was born in Grenada and grew up in Barbados. He earned an undergraduate degree at Johns Hopkins University and holds a medical degree from Harvard Medical School, He completed postgraduate training in internal medicine at the Brigham and Women’s Hospital, and cardiology and interventional cardiology fellowships at Johns Hopkins Hospital. He is board certified in internal medicine, cardiology, interventional cardiology, and nuclear cardiology. In addition to interventional cardiology, his interests include general and preventive cardiovascular medicine. He has lectured on women and heart disease throughout the Caribbean.


Maria Bella, M.S., R.D., CDN

Board of Directors, Northeast Chapter,
National Lipid Association
Clinical Nutrition Coordinator,
New York University School of Medicine
New York, New York

Biography   Maria Bella is an experienced and educated registered dietitian in New York, NY. She specializes in weight loss, eating disorders, sports nutrition, and fitness.

Kevin L. Billups, M.D.

Director, Integrative Men's Health Center and Men's Health and Vitality Program
Associate Professor, Urology and Medicine
Brady Urological Institute
Johns Hopkins Outpatient Center
Baltimore, Maryland 
Biography   Dr. Billups’ area of clinical and research expertise involves the use of erectile dysfunction and testosterone deficiency as gender-specific markers for early detection and prevention of chronic medical conditions, such as diabetes, heart disease and hypertension. He also has expertise in penile prosthetic surgery for men who do not respond to medical management. Dr. Billups is actively involved in creating a multidisciplinary men’s health program that addresses both traditional medical therapies and the social determinants of health to promote prevention and early stage management of the chronic medical diseases which are known to be major contributors to premature death and suffering among men.

Eliot Brinton, M.D.

Director, Metabolism Section, Cardiovascular Genetics Department
Associate Professor, University of Utah School of Medicine
Salt Lake City, Utah
Biography   Dr. Brinton, obtained his medical degree from the University of Utah, completed a residency in internal medicine at Duke University, and received fellowship training in metabolism, endocrinology, and nutrition at the University of Washington in Seattle. Dr. Brinton is currently the president of the Utah Atherosclerosis Society Endocrinology and a founding board member both of the National Lipid Association and of the American Board of Clinical Lipidology in the United States. He is Past- President of the Pacific Lipid Association, the western regional chapter of the National Lipid Association. Dr. Brinton is widely published in the field of lipoprotein metabolism, having published original research articles in the New England Journal of Medicine, JAMA, and Circulation. He is assistant editor of the Journal of Obesity, has served as section editor of Current Opinion in Atherosclerosis and is on the editorial boards of the Journal of Clinical Endocrinology and Metabolism, the Journal of Managed Care Pharmacy and Future Lipidology. He has held numerous leadership and advisory positions in scientific and governmental organizations and in the pharmaceutical industry

Jonathan Cohen, Ph.D.
Professor, Endowed Title C. Vincent Prothro Distinguished Chair in Human Nutrition Research
Department of Internal Medicine, Eugene McDermott Center for Human Growth and Development
Graduate Programs Genetics and Development
University of Texas Southwestern Medical Center
Dallas, Texas
Biography   Dr. Cohen received his Ph.D. from the University of Cape Town in 1989 then did postdoctoral studies at UT Southwestern where he has remained ever since.  His research focuses on the genetic basis of metabolic disorders that contribute common diseases such as heart disease and fatty liver disease. Together with his scientific partner, Dr. Helen Hobbs, he has identified genes that play major roles in the metabolism of fats, cholesterol, and triglycerides, and elucidated the biological roles of their protein products. His laboratory showed that loss-of-function mutations in PCSK9 are associated with low plasma levels of cholesterol and confer protection from coronary heart disease.  In addition, the Hobbs-Cohen laboratory identified the first genetic cause of nonalcoholic fatty liver disease in humans.

Thomas Dayspring, M.D., FACP, FNLA, NCMP

Director of Cardiovascular Education
Foundation for Health Improvement and Technology
Wayne, New Jersey
Biography   Dr. Dayspring is the author of several textbook chapters and peer-reviewed articles, CME publications relating to lipids (including strerols) and lipoproteins including their pharmacologic modulation and their relationship to gender, estrogen and raloxifene. He also authors “Lipidaholics Anonymous” a newsletter received by several thousand healthcare professionals.

James Ehrlich, M.D.

Clinical Associate Professor (Endocrinology)
University of Colorado
Denver, Colorado
Biography   Dr. Ehrlich established Early Detection Technologies, LLC which advises on best practices involving novel biomarkers, diagnostic testing and cardiovascular risk assessment, imaging technologies and radiation protection.     Switching careers from anesthesiology to personalized preventive/diagnostic medicine with “high tech risk assessment”, he founded and became the medical director of Colorado Heart and Body Imaging in Denver. 
    Teaching and communicating new ideas and introducing emerging technologies to the physician and proactive citizen have been an avocation. Considered an authority in the integration of imaging, physiologic and laboratory diagnostic technologies with conventional office based assessment, Dr. Ehrlich has delivered over 200 lectures to physician audiences on 5 continents and is the course co-director for two annual symposia on preventive medicine and preventive cardiology.
    Involved in atherosclerosis research with investigators at two medical schools, Dr. Ehrlich is a founding member of the Society of Atherosclerosis Imaging and a co-founder of the Society of Cardiovascular CT. He is an active contributor to and task force member of SHAPE—the Society for Heart Attack Prevention and Eradication. Most of his research has focused on the monitoring of subclinical atherosclerosis in insulin resistant states and in Type 1 diabetes. More recent research involves atherosclerosis in kidney failure patients and clinical studies involving biologic radiation protection. 

Anthony Gonzalez, M.D.
Chief of Surgery and Minimally Invasive and Robotic Surgery, Baptist Hospital
Medical Director, South Miami Hospital’s Weight-loss Surgery Program
General Surgeon, Baptist and South Miami Hospitals
Miami, Florida
Biography coming soon.


Sharonne Hayes, M.D., FACC, FAHA

Professor of Medicine and Cardiovascular Diseases
Founder, Women’s Heart Clinic
Director of Diversity and Inclusion
Mayo Clinic, Rochester, Minnesota
Biography   Dr. Hayes is a nationally recognized educator and speaker on women’s health and cardiovascular issues and has been involved in developing numerous medical educational programs on women’s health topics for both medical professionals and the public.  She co-directed the long running and award winning continuing medical education program “Controversies in Women’s Health” and co-produced and hosted “Perspectives in Women’s Health”, Mayo Clinic’s continuing medical education live video-teleconference series from 1998 through 2006. In 2004, Dr. Hayes co-produced the Emmy-nominated PBS show, “Call to Action: Women and Heart Disease”. In 2011 she co-hosted and moderated In the Prime of Her Life — A Mayo Clinic Media Briefing on Women and Heart Disease held in February at the Paley Center for Media in New York City.  She has been a guest on the Today Show, Good Morning America, the Charlie Rose Show, CNN Morning Show, Talk of the Nation, and the Dr. Oz Show among others, and has also done live medical reporting for a local ABC affiliate. She serves on the advisory board for Woman’s Day, Diabetic Living, and Women’s Health magazines, and previously wrote a regular column for Better Homes and Gardens’ Heart Healthy Living.

Stanley Hazen, M.D., Ph.D.

Chair, Department of Cellular and Molecular Medicine
Vice-chair, Translational Research, Lerner Research Institute
Director, Center for Cardiovascular Diagnostics and Prevention
Cleveland Clinic
Cleveland, Ohio
Biography   Dr. Hazen has published over 200 peer-reviewed articles, invited reviews and book chapters in the fields of atherosclerosis, oxidation and inflammation chemistry, and cardiovascular disease. He has received many honors and awards for his research work, which has contributed to new understandings of inflammation in cardiovascular disease and the development of new diagnostic and treatment tools. He is listed as a co-inventor on multiple patents for his work in identifying patients at increased risk for cardiovascular disease, diagnosing asthma, and treating inflammation and associated complications. He has been principal investigator on numerous National Institutes of Health grants and research awards related to his specialty interests. He serves as reviewer for more than 20 scientific journals including Circulation, Analytical Biochemistry, Journal of Clinical Investigation, Journal of Biological Chemistry and the Journal of Lipid Research. Dr. Hazen is Associate Editor of the Journal of Lipid Research, and serves on the editorial board of Circulation, The Journal of Biological Chemistry and Free Radicals in Biology & Medicine.

Mark Houston, M.D., M.S., ABAARM, FACP, FAHA, FASH

Associate Clinical Professor of Medicine, Vanderbilt University School of Medicine
Director, Hypertension Institute and Vascular Biology and Life Extension Institute
St. Thomas Medical Group and Vascular Institute of St. Thomas Hospital
Nashville, Tennessee
Biography   Dr. Mark C. Houston graduated from Vanderbilt medical school in 1974, completed a medical internship and residency at the University of California at San Francisco, then returned to Vanderbilt Medical Center as chief resident in medicine. Dr. Houston is on the Consulting Editorial Board or is a consulting reviewer for over 20 major US medical journals. Also, he serves as a member of the Editorial Board and Chair of the Medical Advisory Board of the American Nutraceutical Association (ANA), Editor-in-Chief for the Journal of the American Nutraceutical Association (JANA), and member of the Trust and Executive Board for the consortium of Southeastern Hypertension Control (COSEHC). Dr. Houston has presented over 7,000 lectures on hypertension nationally and internationally, published over 150 articles and scientific abstracts in peer reviewed journals as well as textbook chapters, handbooks and films. He has authored over 70 clinical research studies in hypertension, hyperlipidemia and cardiovascular disease. The best-selling books that he has written include the Handbook of Antihypertensive Therapy, Vascular Biology for the Clinician, and What Your Doctor does not tell you about Hypertension: the Revolutionary Nutrition and Lifestyle Program to help fight High Blood Pressure.

Harlan M. Krumholz, M.D.

Harold H. Hines Jr. Professor of Medicine (Cardiology)
Professor of Investigative Medicine and of Public Health (Health Policy)
Director, Clinical Scholars Program
Director, Yale-New Haven Hospital Center for Outcomes Research and Evaluation
New Haven, Connecticut
Biography   Dr. Krumholz has led research and initiatives to improve the quality and outcomes of clinical decisions and health care delivery, reduce disparities, enable transparency in practice and research and avoid wasteful practices. Dr. Krumholz established the Yale Big Data to Knowledge initiative, a multidisciplinary effort to use advanced analytics to solve health care problems and co-directs the Yale University Research Computing Center. He is a leading expert for national research initiatives in China and recently received the Friendship Award from the government, its highest recognition of foreign experts. Dr. Krumholz is a member of the Institute of Medicine, the Association of American Physicians and the American Society for Clinical Investigation. He is a Distinguished Scientist of the American Heart Association. He is on the Board of Governors of the Patient-Centered Outcomes Research Institute and the Advisory Committee to the Director of the National Institutes of Health. Dr. Krumholz received a BS from Yale, an MD from Harvard Medical School, and a Masters in Health Policy and Management from the Harvard University School of Public Health.

Ralph La Forge, MSc, CLS, FNLA

Clinical Lipid Specialist, Clinical Exercise Physiologist 
Duke Lipid Clinic & Disease Management
Durham, North Carolina
Biography   Ralph La Forge is a clinical exercise physiologist. He is former Managing Director of the Duke Lipid Disorder Physician Education Program at Duke University Medical Center, Division of Endocrinology, Metabolism and Nutrition where he is now consulting faculty. Mr. La Forge is a senior faculty for the U.S. Indian Health Service Diabetes Treatment and Prevention Division in Albuquerque New Mexico, and currently serves as president of the Accreditation Council for Clinical Lipidology, which certifies advanced practice clinical professionals in clinical Lipidology. He is also President Elect of the Southeast Lipid Association. Mer. La Forge has helped over 300 medical staff groups throughout North America organize and operate cholesterol disorder, preventive endocrinology and cardiology programs. He has published over 350 professional and consumer publications on cardiometabolic risk reduction and applied exercise science.

Donald Lloyd-Jones, M.D., ScM, FACC, FAHA

Chair, Department of Preventive Medicine
Senior Associate Dean, Clinical and Translation Research
Director, Northwestern University Clinical and Translational Sciences (NUCATS) Institute
Eileen M. Foell Professor of Preventive Medicine
Northwestern University
Chicago, Illinois
Biography   Dr. Lloyd-Jones’ research interests include cardiovascular disease epidemiology, risk estimation, and prevention. A main focus of his research has been investigation of the lifetime risks for various cardiovascular diseases, and factors which modify those risks. Other areas of interest include CVD risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, and the epidemiology of hypertension. His clinical and teaching interests lie in general cardiology, with a focus on prevention. He chaired the committee and authored the monograph that defined and set the American Heart Association’s Strategic Impact Goals for 2010-2020, including a bold new focus on cardiovascular health promotion. He was co-chair of the Risk Assessment Work Group and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction. He has authored over 250 scientific publications to date. In 2014, he was named by Thomson Reuters as a “Highly Cited Researcher,” a distinction reserved for investigators in the top 1% by total citations of highly cited papers in their scientific field (in this case, medicine) during the period 2002-2012. Dr. Lloyd-Jones actively mentors numerous junior investigators. Recent awards and honors received by his primary mentees include: the American Heart Association Elizabeth Barrett-Connor Young Investigator Award (1 winner, 1 finalist); Fellow and Junior Faculty Awards for Best Clinical Science at the National Cardiovascular Young Investigators’ Forum (4 mentee awards); the Jameson Award for Excellence in Fellows’ Research (3 mentees) at Northwestern; the Bonow Award for Excellence in Fellows’ Research in Cardiovascular Disease at Northwestern (4 mentees); NIH R01, K23, K99, K12, F32, R21, Fogarty International, Fulbright, LRP, AHA and institutional grants; and first prizes in poster competitions at numerous local and national meetings.

Joseph Loizzo, M.D., Ph.D  

Director, Nalanda Institute for Contemplative Science
Weill Cornell Center for Integrative Medicine 
Columbia University Center for Buddhist Studies
New York, New York
Biography   Dr. Joseph (Joe) Loizzo is a Harvard-trained psychiatrist and Columbia-trained Buddhist scholar with over thirty years' experience studying the beneficial effects of meditation on healing and learning. He is an Assistant Professor of Clinical Psychiatry in Integrative Medicine at Weill Cornell Medical College, where he researches and teaches mind/body health. He has taught science and religion, the scientific study of religious experience, and the Indo-Tibetan mind sciences at Columbia University. Dr. Loizzo has published numerous scientific articles and scholarly chapters on the challenges of researching Indo-Tibetan mind and health science, the role of mind-body methods in modern medicine and psychiatry, and meditative approaches to psychotherapy and health education. These include three articles in the recent New York Academy of Sciences volume, Longevity, Regeneration and Optimal Health, edited by Nalanda faculty Drs. Erin Olivo, Bill Bushell and Neil Theise. His translation study, Nagarjuna’s Reason Sixty with Candrakirti’s Commentary, was one of the inaugural volumes in the American Institute of Buddhist Studies Translation Series distributed by the Columbia University Press.

Robert Lustig, M.D.

Professor of Clinical Pediatrics, Division of Endocrinology
Director, UCSF Weight Assessment for Teen and Child Health (WATCH) Program
University of California
San Francisco, California
Biography   Dr. Lustig is a nationally-recognized authority in the field of neuroendocrinology, with a specific emphasis on the regulation of energy balance by the central nervous system. He is currently investigating the contribution of biochemical, neural, hormonal, and genetic influences in the expression of the current obesity epidemic both in children and adults. He has defined a syndrome of vagally-mediated beta-cell hyperactivity which leads to insulin hypersecretion and obesity, and which is treatable by insulin suppression. This phenomenon may occur in up to 20% of the obese population. He is interested in the hypothalamic signal transduction of insulin and leptin, and how these two systems interact. He is studying the cardiovascular morbidity associated with hyperinsulinemia, and developing methods to evaluate and prevent this phenomenon in children. He is also analyzing the contribution of the autonomic nervous system to insulin secretion and insulin resistance in obese children, and the utility of assessing insulin dynamics in targeting obesity therapy. Dr. Lustig has authored over 70 research articles and 35 chapters.

Carl E. Orringer, FACC, FNLA

Associate Professor of Medicine
University of Miami Miller School of Medicine
Miami, Florida
President, National Lipid Association

Biography   Dr. Orringer is now President of the National Lipid Association. He has been an editorial reviewer and faculty contributor to the National Lipid Association Self Assessment Programs and to the Complex Lipid Management Self-Assessment Programs. He was a contributing editor to the American Diabetes Association Self Assessment Program in Lipoprotein Management in Patients with Type 2 Diabetes and Cardiometabolic Risk and to the Johns Hopkins University Self-Assessment Program on the Clinical Utility of Non-HDL Cholesterol in the Management of Dyslipidemia. Dr. Orringer has authored multiple peer-reviewed clinical papers, and has recently served on several National Lipid Association Expert Panels that have developed recommendations for the dyslipidemia management. He has written several book chapters and co-authored The Grocery Shopping Guide, the first consumer-directed book to analyze grocery products to help the public make more informed decisions about the groceries they purchase. He developed and implemented the EDUCATE program, a novel coronary calcium scoring-based lipid management program at University Hospitals Case Medical Center in 2007 where he engaged in research examining novel cellular and molecular biomarkers and their association with coronary calcium scoring and cardiovascular outcomes in patients with HIV/AIDS.Dr. Orringer is a co-author of the NLA recommendations. He is a fellow of the ACC and the NLA, where he is president-elect. 

Sandra Revill Tremulis
Founder, Lipoprotein(a) Foundation
San Carlos, California
Biography   Sandra Revill Tremulis is the Founder of the Lipoprotein(a) Foundation, with the vision  to live in a world where elevated Lp(a) is routinely diagnosed, treated and family screened. There is currently no treatment for high Lp(a). The foundation has a long way to go, but they are starting the conversation about inherited premature cardiovascular disease due to high Lipoprotein(a). Sandra does not want anyone to experience the tragic loss of a family member.  She wants the research data -- and a treatment -- to be in place to help her daughter and all those children who have a high risk of inheriting elevated Lp(a) from their parents, to protect them from these serious and tragic risks. 

Raul Santos, M.D.

Associate Professor of Cardiology
Director Lipid Clinic Heart Institute (InCor)
Scientific Advisor Preventive Medicine Center Hospital Israelita Albert Einstein
São Paulo, Brazil
Biography   Dr. Santos, research interests include lipid metabolism, severe forms of genetic dyslipidemia, especially familial hypercholesterolemia and HDL deficiency, non-alcoholic fatty liver disease and imaging in atherosclerosis especially detection of vascular calcification. Dr Santos collaborated in research studies with the Ciccarone Preventive Cardiology Center of the Johns Hopkins University in Baltimore, USA, the Lipid Metabolism Laboratory of the Tufts University in Boston, USA and the HJELT Institute, Department of Public Health, University of Helsinki in Finland. He has published more than 130 papers in peer-review journals like the Lancet, Atherosclerosis, ATVB, Circulation, Cardiovascular Research, The European Heart Journal, JACC, Journal of Lipid Research and Current Opinion of Lipidology among others. Dr. Santos has coordinated and participated in many Brazilian and International guidelines on dyslipidemia and atherosclerosis prevention, metabolic syndrome, obesity, diabetes and coronary heart disease.

James Underberg, M.D. M.S., FACPM, FACP, FASH, FNLA

Clinical Assistant Professor of Medicine, Division of General Internal Medicine
NYU Medical School and NYU Center for Cardiovascular Disease Prevention
Director, Bellevue Hospital Primary Care Lipid Management Clinic
New York, New York
Biography   Dr. Underberg’s clinical specialty is Clinical Lipidology. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension and a Diplomate of the American Board of Clinical Lipidology. Dr. Underberg is president-elect of the Northeast Chapter of the National Lipid Association. He was also serves on the National Board of the National Lipid Association for the term 2011-2014. He is a member of the editorial board of the Journal of Clinical Lipidology, co-chairs the communication committee of the NLA and is the co-editor of the NLA quarterly newsletter Lipid Spin. Dr. Underberg also serves as the Co-Chair and faculty for the National Lipid Association Lipid Academy & Lipid University. He currently serves on the CME committee of the American Society of Hypertension. Dr. Underberg graduated from Yale University with a BS and MS and from the University of Pennsylvania Medical School. His internship and residency were completed at NYU-Bellevue Hospital Medical Center. He has been elected a fellow of the American College of Preventive Medicine, the Society of Vascular Medicine, the National Lipid Association and the American College of Physicians and the American Society of Hypertension. He is currently involved in several clinical trials in the areas of hypertension, lipids, diabetes and cardiovascular disease prevention. He sees patients both in a university based referral practice and in the Bellevue Hospital Lipid Clinic.

Michael Weber, M.D.

Professor of Medicine
SUNY Downstate Medical Center College of Medicine
Brooklyn, New York
Biography   Dr. Weber’s career has been focused primarily on hypertension and preventive cardiology. He has published numerous research articles in the medical literature and has authored or edited 16 books. Together with Dr. Suzanne Oparil, he is responsible for the widely used reference volume, Hypertension. Dr. Weber is the Editor-in-Chief of The Journal of Clinical Hypertension. Dr. Weber was one of the founders of The American Society of Hypertension and has served as its President. He also served as Chair of the ASH Hypertension Specialists Program. He is a Fellow of The American College of Physicians, The American College of Cardiology and The American Heart Association. He has served on the Cardiovascular and Renal Drugs Advisory Board of the Food and Drug Administration, and continues as a consultant to that Agency. He has also served for ten years as Chairman of the Formulary Committee of a major pharmacy benefits provider serving many of the leading health plans in the United States. His main current research interests are in clinical trials of patients at high risk of cardiovascular events or strokes. He is also participating actively in trials in patients with metabolic disorders such as diabetes and kidney disease. Dr. Weber currently serves on the Steering Committees of several national and international clinical outcomes trials.

Eric Westman, M.D.

Director, Duke Lifestyle Medicine Clinic
Duke University
Durham, North Carolina
Biography coming soon.



Disclosures and Resolution of Conflict of Interest
Baptist Health South Florida requires resolution of all conflicts of interest to ensure balance, independence, objectivity, and scientific rigor in all CME programming. Conflicts of interest of any individuals who control CME content will be identified and resolved prior to this educational activity. Full disclosure will be made in the syllabus. Presenters will also disclose discussion of off-label uses.